Tag: Breast cancer drug Kisqali
FDA Approves Kisqali for Early-Stage Breast Cancer Treatment
The FDA has recently approved Kisqali, a drug initially used to treat metastatic breast cancer, for the treatment of early-stage breast cancer as well....
BREAKING NEWS
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee...
